| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.06 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.07 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |